Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Latest News about bluebird bio, Inc/
Recent news which mentions bluebird bio, Inc/
Cell and gene therapy firm raises $170M investment
March 30, 2020
Tags
Health Care
MPM Capital
Invus Group LLC
From
Business Journals
Biotech delays U.S. gene therapy launch due to outbreak, FDA discord
March 26, 2020
Tags
Coronavirus
Health Care
Government & Regulations
From
Business Journals
Blood disorder startup files for $86M IPO
February 19, 2020
Tags
Vertex Pharmaceuticals
New Enterprise Associates, Inc/
CRISPR Therapeutics AG
From
Business Journals
Acceleron stock soars on lung drug trial data
January 28, 2020
Tags
Celgene Corporation
Health Care
CRISPR Therapeutics AG
From
Business Journals
CRISPR Therapeutics stock jumps on early gene editing data
November 19, 2019
Tags
bluebird bio Inc/ (Cambridge MA)
Vertex Pharmaceuticals Incorporated
Editas Medicine
From
Business Journals
FDA approves Acceleron's blood disorder drug ahead of schedule
November 08, 2019
Tags
Acceleron Pharma Inc/
bluebird bio, Inc/
Beam Therapeutics (Cambridge MA)
From
Business Journals
These 36 Mass. firms made Deloitte's Technology Fast 500
November 07, 2019
Tags
Deloitte
Technology
Jessica Ackerman
From
Business Journals
LabCentral gets state, private funds for new biomanufacturing lab space
October 01, 2019
Tags
Johannes Fruehauf
Biotech
Boeing
From
Business Journals
Bluebird prices gene therapy in Europe at $1.8M over 5 years
June 14, 2019
Tags
Insurance
Spark Therapeutics
bluebird bio, Inc/
From
Business Journals
Chicago biotech sues Third Rock, bluebird bio CEO over gene therapy license
June 13, 2019
Tags
bluebird bio, Inc/
Pharmaceuticals
Insurance
From
Business Journals
Here's how much top biotechs spent on R&D last quarter
June 10, 2019
Tags
bluebird bio Inc/ (Cambridge MA)
Sage Therapeutics Inc/ (Cambridge MA)
Vertex Pharmaceuticals Incorporated
From
Business Journals
Life sciences VC firm Third Rock raises $770M in its largest round ever
June 06, 2019
Tags
Agios
Health Care
Blueprint Medicines Corp/ (Cambridge MA)
From
Business Journals
Massachusetts concern details plan to hire new workers in Durham
March 25, 2019
Tags
bluebird bio, Inc/
Tony Copeland
Nick Leschly
From
Business Journals
13 local life sciences drugs and devices to watch in 2019
January 01, 2019
Tags
Insurance
Bioscience
Sarepta Therapeutics Inc/ (Cambridge MA)
From
Business Journals
East Bay biotech's different approach to cancer leads to $80 million IPO
August 23, 2018
Tags
Pharmaceuticals
Clarus Ventures
bluebird bio, Inc/
From
Business Journals
Bluebird partners with Bay Area biotech on new cancer drug targets
August 23, 2018
Tags
Biotech
Philip Gregory
bluebird bio, Inc/
From
Business Journals
Why this company's Durham outpost may benefit from $100M investment
August 07, 2018
Tags
Derek Adams
bluebird bio, Inc/
Health Care
From
Business Journals
Spark Therapeutics, Bluebird CEOs formulate a Super Bowl wager
February 02, 2018
Tags
Spark Therapeutics
Pharmaceuticals
Biotech
From
Business Journals
Cambridge biotechs among big winners at ASH blood disease conference
December 10, 2017
Tags
Agios
Vertex Pharmaceuticals
Health Care
From
Business Journals
Massachusetts company buys Argos facility for Durham expansion
November 30, 2017
Tags
Commercial Real Estate
Crane Watch All Markets
Health Care
From
Business Journals
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.